Wei‐Fen Xie
- Hepatology top 0.5%
- Liver physiology and pathology 32
- Liver Disease and Transplantation 11
- Cancer Research top 2%
- MicroRNA in disease regulation 11
- Oncology top 5%
- Molecular Biology top 5%
- RNA modifications and cancer 7
- Epidemiology top 2%
- Liver Disease Diagnosis and Treatment 33
- Hepatitis B Virus Studies 9
-
- Pancreatic function and diabetes 11
-
- interferon and immune responses 7
- Cited by
- HepatologyCancer ResearchOncology
- Journals
- Journal of Biological Chemistry (2 papers)Nature Communications (1 paper)Gastroenterology (2 papers)
- Partner nations
- ChinaUnited StatesSpain
In The Last Decade
Wei‐Fen Xie
110 papers receiving 4.3k citations
Peers
Comparison fields: 5 of 125
- Hepatology 1.2k
- Cancer Research 999
- Oncology 905
- Molecular Biology 2.1k
- Epidemiology 1.0k
Countries citing papers authored by Wei‐Fen Xie
This map shows the geographic impact of Wei‐Fen Xie's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wei‐Fen Xie with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wei‐Fen Xie more than expected).
Fields of papers citing papers by Wei‐Fen Xie
This network shows the impact of papers produced by Wei‐Fen Xie. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wei‐Fen Xie. The network helps show where Wei‐Fen Xie may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Wei‐Fen Xie, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 11 | |
| 3 | 2025 | 6 | |
| 4 | 2024 | 8 | |
| 5 | 2024 | 2 | |
| 6 | 2024 | 1 | |
| 7 | 2024 | 3 | |
| 8 | 2023 | 7 | |
| 9 | 2023 | 14 | |
| 10 | 2023 | 1 | |
| 11 | 2022 | 37 | |
| 12 | 2021 | 92 | |
| 13 | 2021 | 6 | |
| 14 | 2019 | 88 | |
| 15 | 2017 | 181 | |
| 16 | 2016 | 0 | |
| 17 | 2010 | 69 | |
| 18 | 2010 | 194 | |
| 19 | 2010 | 1 | |
| 20 | [Inhibition of proliferation of hepatic stellate cells by taurine is mediated via regulating cell cycle proteins]. | 2005 | 1 |
About Wei‐Fen Xie
Wei‐Fen Xie is a scholar working on Hepatology, Epidemiology and Cancer Research, having authored 116 papers that have together received 4.3k indexed citations. Recurring topics across this work include Liver Disease Diagnosis and Treatment (33 papers), Liver physiology and pathology (32 papers), MicroRNA in disease regulation (11 papers), Liver Disease and Transplantation (11 papers), Pancreatic function and diabetes (11 papers), Hepatitis B Virus Studies (9 papers), interferon and immune responses (7 papers) and RNA modifications and cancer (7 papers). The work is most often cited by research in Hepatology (1.2k citations), Cancer Research (999 citations) and Oncology (905 citations). Wei‐Fen Xie has collaborated with scholars based in China, United States and Spain. Frequent co-authors include Yue-Xiang Chen, Beifang Ning, Jin Ding, Chuan Yin, Xin Zeng, Hongyang Wang, Xin Zhang, Xing Deng, Yong Lin and Jian Shi. Their work appears in journals such as Journal of Biological Chemistry, Nature Communications and Gastroenterology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.